GE HealthCare Technologies logo

GE HealthCare Technologies

GEHCNASDAQStock Fundamentals

GE HealthCare is a global medical technology and pharmaceutical diagnostics company that provides advanced medical devices, imaging agents, and digital health solutions. The company focuses on delivering precision care through a combination of hardware, AI-enabled software, and clinical services to help clinicians diagnose and treat complex diseases. Its value proposition centers on integrating diagnostic tools with data-driven insights to improve patient outcomes and operational efficiency for healthcare providers.

Market Cap$28.0B
Revenue TTM$21.0B
Net Income TTM$1.9B
P/E Ratio14.66
Net Margin9.1%
EPS TTM$4.17
Free Cash Flow TTM$1.5B
Employees51.0K
CEOPeter J. Arduini
CountryUnited States of America
Healthcare
Medical - Healthcare Information Services
SegmentsMedical Devices, Diagnostics, Healthcare Information Technology, Pharmaceuticals
Business ModelsEquipment sales, Subscription SaaS, Recurring consumables, Maintenance services, Professional services
Most Recent EarningsApr 29, 2026 · 21 days agoQ1 2026
View report
Next EarningsJul 29, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Gross Margin39.15%
Op. Margin12.63%
ROE19.23%
D/E99.21%
Current Ratio1.22
Total Debt$10.6B
CapEx TTM$508.0M

Gross Profit

View metric

Net Income

View metric

Operating Cash Flow

View metric

Free Cash Flow

View metric

EPS (Diluted)

View metric

Business Segments

Imaging

primary

Provides a comprehensive suite of scanning technologies and AI-enabled software to visualize anatomical structures and functional processes. These solutions support clinical specialties including oncology, cardiology, and neurology.

Products

Molecular Imaging (MI), Computed Tomography (CT), Magnetic Resonance (MR), PET/CT, PET/MR, SPECT, Women’s Health X-ray, Fixed room radiography

Customers

Hospitals, Imaging centers, Academic institutions, Public and private health systems

Advanced Visualization Solutions (AVS)

major

Focuses on specialized ultrasound and procedural guidance technologies designed for specific clinical workflows. This segment supports diagnostic, interventional, and surgical settings with real-time imaging and AI-guided instructions.

Products

Comprehensive Care Ultrasound, Women’s Health Ultrasound, CardioVascular and Interventional Solutions, Surgical Innovations mobile C-arms, AI-guided ultrasound software

Customers

Surgical centers, Cardiology clinics, Obstetrics and gynecology practices, Operating rooms

Patient Care Solutions (PCS)

major

Delivers monitoring and life support systems that aggregate clinical data in real time to support clinical decision-making. The segment includes a significant portfolio of recurring revenue through consumables and digital service subscriptions.

Products

Patient Monitoring systems, Diagnostic Cardiology (ECG/EKG), Maternal Infant Care (incubators, warmers), Anesthesia delivery systems, Clinical consumables, Digital Solutions decision support software

Customers

Labor and delivery departments, Neonatal intensive care units, Ambulatory surgical centers, Hospitals

Pharmaceutical Diagnostics (PDx)

major

Develops and supplies contrast media and radiopharmaceuticals used in medical imaging to enhance the visibility of tissues and assess cell function. This segment operates a sophisticated global supply chain for time-sensitive molecular tracers.

Products

Contrast media, Radiopharmaceuticals, Molecular tracers, Contrast injection devices

Customers

Radiology departments, Nuclear medicine clinics, Pharmaceutical companies, Research institutions

Segment Financials

Imaging — Total revenues

View metric

Imaging — Acquisitions

View metric

Imaging — Costs and Expenses

View metric

AVS — Acquisitions

View metric

AVS — Goodwill

View metric

AVS — EBIT

View metric

PCS — Total revenues

View metric

PCS — Cost of Sales

View metric

PCS — Costs and Expenses

View metric

PDx — Total revenues

View metric

PDx — Cost of Sales

View metric

PDx — Acquisitions

View metric

Business Overview

Competitive Position

A leading global provider with a 130-year history and a massive installed base of connected devices across 160 countries.

Geographies

Global, United States, Europe, Emerging Markets

Customer Segments

Hospitals, Health systems, Government institutions, Academic researchers

Upstream Dependencies

Radioisotope suppliers, Electronic component manufacturers, Raw material suppliers for contrast media, Software developers

Downstream Customers

Public hospitals, Private health systems, Diagnostic laboratories, Clinical research organizations

GE HealthCare Technologies logo

GE HealthCare Technologies FAQ

Common questions about GE HealthCare Technologies

GE HealthCare is a global medical technology and pharmaceutical diagnostics company that provides advanced medical devices, imaging agents, and digital health solutions. The company focuses on delivering precision care through a combination of hardware, AI-enabled software, and clinical services to help clinicians diagnose and treat complex diseases. Its value proposition centers on integrating diagnostic tools with data-driven insights to improve patient outcomes and operational efficiency for healthcare providers.

GE HealthCare Technologies (GEHC) has a market capitalization of $28.0B and trades on NASDAQ.

GE HealthCare Technologies generated $21.0B in trailing twelve-month revenue with net income of $1.9B, representing a net margin of 9.1%. Gross margin stands at 39.1%, with free cash flow of $1.5B. These figures are based on the Q1 2026 filing.

GE HealthCare Technologies's key competitors include Medtronic plc, Philips Healthcare, Danaher Corporation, and others. These companies compete in similar markets and product categories.

GE HealthCare Technologies has approximately 51,000 employees.